Newsroom Inflammatix in the news How a young Peninsula company snagged a onetime Roche exec to battle sepsis Dec 19, 2017 Diagnosis: Frontiers in blood testing Sep 28, 2017 Wanted: More Data, the Dirtier the Better. Embracing messy data as a way to capture the messiness of disease Jun 12, 2017 Stanford Spinout Inflammatix Developing Sepsis Diagnostic Based on Host Immune Response May 24, 2017 Researchers at the Stanford School of Medicine Develop Cutting-Edge Test to Identify Whether an Infection is Bacterial or Viral Oct 24, 2016 A Blood Test to Determine when Antibiotics are Warranted Jul 6, 2016 Do You Really Need Antibiotics? This Test Can Tell. Jul 6, 2016 Simple blood test distinguishes between viral, bacterial infections Jul 6, 2016 Interview with Tim Sweeney, MD, PhD, Co-Founder of Inflammatix (begins @ 19:40) Jul 28, 2015 Recent News Inflammatix Checks off All the Right Boxes with Investors Mar 19, 2021 Inflammatix nets $102M to advance its immune system tests for infectious diseases Mar 16, 2021 Infection-detection system from Peninsula company scores $102M, aims to hit market this year Mar 16, 2021 Older NewsRecent News Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force Mar 18, 2020 Inflammatix named to Fierce 15 MedTech list Mar 9, 2020 New Technologies Can Step Up Fight Against Antimicrobial Resistance and Sepsis Jan 10, 2020 Inflammatix raises $32M, plus a BARDA contract, for its point-of-care infection diagnostics Jan 10, 2020 Inflammatix Raises $32M in Series C Financing Jan 10, 2020 Genetic platform takes the guesswork out of catching infections Dec 4, 2019 Older NewsRecent News Press releases Oct 4, 2018 Inflammatix to Present New Data at IDWeek 2018 Demonstrating Ability to Perform HostDx™ Fever Test to Rapidly Distinguish Bacterial from Viral Infections Across Multiple Laboratory Platforms Apr 10, 2018 Inflammatix Named a Finalist in Fast Company’s 2018 World Changing Ideas Awards for Its Novel HostDx Tests Feb 15, 2018 New Study Published in Nature Communications Suggests Sepsis Can Be Detected By Measuring the Immune System Dec 19, 2017 Inflammatix Announces Appointment of Oliver Liesenfeld, M.D., as Chief Medical Officer Recent Press Releases Machine learning blogs Podcasts Diagnosing Infection with Ljubomir Buturovic from Inflammatix December 2023 Advances in Sepsis Diagnostics: the HostDx Sepsis Platform May 2018 Media Contact [email protected]
Wanted: More Data, the Dirtier the Better. Embracing messy data as a way to capture the messiness of disease Jun 12, 2017
Researchers at the Stanford School of Medicine Develop Cutting-Edge Test to Identify Whether an Infection is Bacterial or Viral Oct 24, 2016
Infection-detection system from Peninsula company scores $102M, aims to hit market this year Mar 16, 2021
Inflammatix raises $32M, plus a BARDA contract, for its point-of-care infection diagnostics Jan 10, 2020
Oct 4, 2018 Inflammatix to Present New Data at IDWeek 2018 Demonstrating Ability to Perform HostDx™ Fever Test to Rapidly Distinguish Bacterial from Viral Infections Across Multiple Laboratory Platforms
Apr 10, 2018 Inflammatix Named a Finalist in Fast Company’s 2018 World Changing Ideas Awards for Its Novel HostDx Tests
Feb 15, 2018 New Study Published in Nature Communications Suggests Sepsis Can Be Detected By Measuring the Immune System
